» Articles » PMID: 36192605

High-intensity Interval Training Ameliorates Endothelial Dysfunction Through Adropin, Nitric Oxide, MR-proADM, and Copeptin Changes in Overweight Subjects

Overview
Specialty Endocrinology
Date 2022 Oct 3
PMID 36192605
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to determine adropin, NO, MR-proADM, and copeptin changes following four different types of high-intensity interval training (HIIT) in men with overweight.

Methods: In the current study, 45 overweight participants were included in the pre-intervention assessments and randomly assigned to the following groups: (1) control, (2) HIIT bike, (3) HIIT short-treadmill, and (4) HIIT long-treadmill groups. The participants were given 10-min sessions of HIIT intervention between 85 and 95% of VO, followed by 1-min inactive recovery at three sessions/week for 8 weeks. Body composition, VO, ultrasound imaging, diabesity-related risk factors, adropin, NO, MR-proADM, and copeptin were also assessed before and following the HIIT interventions.

Results: There was a statistically significant elevation in adropin and NO levels (p < 0.05), while MR-proADM and copeptin were notably more decreased than those of the control group following the 8 weeks of HIIT interventions (p < 0.01). However, no statistically significant decrease was observed in carotid/femoral intima-media thickness (c/f-IMT) values following the 8-week HIIT interventions, while statistically significant reductions were demonstrated in participants who had no atherosclerotic plaque or IMT < 0.9 mm (p < 0.05).

Conclusions: In conclusion, HIIT had a greater effect on IMT remodeling of the femoral artery than of the carotid artery. Decreased MR-proADM and copeptin and increased adropin levels might act as a physiological surrogate of endothelial dysfunction through increased NO-related signaling pathways in participants with overweight following high-intensity interval training.

Citing Articles

Role of the Unique Secreted Peptide Adropin in Various Physiological and Disease States.

Hasanpour-Segherlou Z, Butler A, Candelario-Jalil E, Hoh B Biomolecules. 2025; 14(12.

PMID: 39766320 PMC: 11674490. DOI: 10.3390/biom14121613.


Unveiling the multifaceted role of adropin in various diseases (Review).

Chen L, Lu J, Hu J, Gong X Int J Mol Med. 2024; 54(4).

PMID: 39155866 PMC: 11335353. DOI: 10.3892/ijmm.2024.5414.


Comparative efficacy of exercise training modes on systemic metabolic health in adults with overweight and obesity: a network meta-analysis of randomized controlled trials.

Wang H, Cheng R, Xie L, Hu F Front Endocrinol (Lausanne). 2024; 14:1294362.

PMID: 38288474 PMC: 10823366. DOI: 10.3389/fendo.2023.1294362.


Genetics of hyperaldosteronism and a wealth of new information on topics ranging from MEN1 to Cushing's disease and metabolic syndrome.

Stratakis C Hormones (Athens). 2022; 21(4):521-523.

PMID: 36380266 DOI: 10.1007/s42000-022-00418-2.

References
1.
Hammond R, Levine R . The economic impact of obesity in the United States. Diabetes Metab Syndr Obes. 2011; 3:285-95. PMC: 3047996. DOI: 10.2147/DMSOTT.S7384. View

2.
Gokce N, Keaney Jr J, Hunter L, Watkins M, Nedeljkovic Z, Menzoian J . Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003; 41(10):1769-75. DOI: 10.1016/s0735-1097(03)00333-4. View

3.
Woo K, Chook P, Yu C, Sung R, Qiao M, Leung S . Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord. 2004; 28(7):852-7. DOI: 10.1038/sj.ijo.0802539. View

4.
Akil L, Ahmad H . Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved. 2011; 22(4 Suppl):61-72. PMC: 3250069. DOI: 10.1353/hpu.2011.0166. View

5.
Schnabel R, Wild P, Schulz A, Zeller T, Sinning C, Wilde S . Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study. Hypertension. 2012; 60(2):288-95. DOI: 10.1161/HYPERTENSIONAHA.112.191874. View